Cetera Advisor Networks’s BioTelemetry, Inc. BEAT Stock Holding History

Cetera Advisor Networks’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,290	Closed	-$58K	–	3438
2020 Q2	$58K	Buy	+1,290	New	+$57.8K	﹤0.01%	1821
2018 Q4	–	Sell	-5,700	Closed	-$368K	–	1185
2018 Q3	$368K	Buy	+5,700	New	+$318K	0.01%	763

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Cetera Advisor Networks's BEAT Position: Q3 2020 in Review

Cetera Advisor Networks sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 1,290 shares — an estimated $58K sold.

Cetera Advisor Networks first reported a position in BEAT in Q3 2018 and held it in 2 quarters. The position peaked at $368K in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

Cetera Advisor Networks reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
Cetera Advisor Networks sold 1,290 BioTelemetry, Inc. shares in Q3 2020, an estimated $58K.
Cetera Advisor Networks first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 2 quarters.
Cetera Advisor Networks's BioTelemetry, Inc. position peaked at $368K in Q3 2018.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.